Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial - The Lancet
Por um escritor misterioso
Last updated 06 outubro 2024
Rationale and design of the AXIOMATIC-SSP phase II trial
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double
Effect of atherosclerosis on 5-year risk of major vascular events
PDF) The new era of anticoagulation: factor XI and XII inhibitors
Asundexian (BAY-2433334), CAS 2064121-65-7
Factor XI inhibitors in patients with cardiovascular disease and a
Poststroke Cardiovascular Management: Current Concepts, Integrated
Design and Preclinical Characterization Program toward Asundexian
JCM, Free Full-Text
JCDD, Free Full-Text
Recomendado para você
você pode gostar